18-72542461-G-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_182511.4(CBLN2):c.-166-135C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.008 in 184,812 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0083   (  14   hom.,  cov: 31) 
 Exomes 𝑓:  0.0065   (  1   hom.  ) 
Consequence
 CBLN2
NM_182511.4 intron
NM_182511.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.671  
Publications
1 publications found 
Genes affected
 CBLN2  (HGNC:1544):  (cerebellin 2 precursor) Predicted to be involved in maintenance of synapse structure and spontaneous synaptic transmission. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in extracellular space. Predicted to be active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 18-72542461-G-T is Benign according to our data. Variant chr18-72542461-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 1316642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00832 (1265/151966) while in subpopulation SAS AF = 0.0394 (189/4800). AF 95% confidence interval is 0.0348. There are 14 homozygotes in GnomAd4. There are 647 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 14  gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CBLN2 | NM_182511.4 | c.-166-135C>A | intron_variant | Intron 2 of 4 | ENST00000269503.9 | NP_872317.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00832  AC: 1264AN: 151848Hom.:  13  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1264
AN: 
151848
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00652  AC: 214AN: 32846Hom.:  1   AF XY:  0.00616  AC XY: 107AN XY: 17358 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
214
AN: 
32846
Hom.: 
 AF XY: 
AC XY: 
107
AN XY: 
17358
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
768
American (AMR) 
 AF: 
AC: 
6
AN: 
954
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
6
AN: 
1148
East Asian (EAS) 
 AF: 
AC: 
18
AN: 
1048
South Asian (SAS) 
 AF: 
AC: 
9
AN: 
284
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
3304
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
178
European-Non Finnish (NFE) 
 AF: 
AC: 
160
AN: 
23104
Other (OTH) 
 AF: 
AC: 
10
AN: 
2058
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 11 
 22 
 32 
 43 
 54 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00832  AC: 1265AN: 151966Hom.:  14  Cov.: 31 AF XY:  0.00871  AC XY: 647AN XY: 74282 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1265
AN: 
151966
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
647
AN XY: 
74282
show subpopulations 
African (AFR) 
 AF: 
AC: 
102
AN: 
41462
American (AMR) 
 AF: 
AC: 
140
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
18
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
118
AN: 
5074
South Asian (SAS) 
 AF: 
AC: 
189
AN: 
4800
European-Finnish (FIN) 
 AF: 
AC: 
16
AN: 
10594
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
664
AN: 
67966
Other (OTH) 
 AF: 
AC: 
16
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 71 
 142 
 212 
 283 
 354 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
107
AN: 
3478
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 30, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.